Related by context. Frequent words. (Click for all words.) 63 Commercialization Agreement 62 Exclusive License 62 Drug Candidate 60 FDA Accepts 60 Smallpox Vaccine 60 Patent Covering 60 FDA Clears 59 Develop Novel 59 Achieves Milestone 59 Influenza Vaccine 59 Generic Version 59 Receives Orphan Drug Designation 58 Licensing Agreements 58 RNAi Therapeutics 58 Cervical Cancer Vaccine 58 Atopic Dermatitis 57 Anthrax Vaccine 57 Initiates Phase II 57 Acquires Exclusive 57 Recombinant Human 57 Phase III Clinical Trial 57 Small Molecule 57 Significantly Improves 56 Patent Issued 56 Malaria Vaccine 56 Intellectual Property Portfolio 56 Explore Strategic Alternatives 56 SBIR Grant 56 Receives Patent 56 Secures Financing 56 Regulatory Approvals 56 Pulmonary Arterial Hypertension 56 Inc Therapeutic Competitors 55 Antifungal 55 Presents Positive 55 Positive Opinion 55 Single Dose 55 Announces FDA Clearance 55 Closes Financing 55 TYGACIL 54 Patent License Agreement 54 Supply Agreements 54 Orphan Drug Status 54 Announces Issuance 54 Marketing Authorisation 54 Stock Repurchase 54 Issues Guidance 54 Gastric Cancer 54 Provides Shareholder 54 Share Repurchases 54 Stock Repurchase Plan 54 Workforce Reduction 54 Patent Infringement Lawsuit 54 Licensing Deal 54 Monoclonal Antibody 54 Announces Initiation 54 Cancer Vaccines 53 Hepatocellular Carcinoma 53 Fast Track Designation 53 Clinical Trial Results 53 Develop Next Generation 53 Prostate Cancer Patients 53 PRIALT 53 Completes Enrollment 53 Private Placement Offering 53 RNA Interference 53 Secures Additional 53 Receives Positive 53 Completes Private Placement 53 Commercialize 53 Ceragenix 53 Allergic Rhinitis 53 Low Dose 53 Files Shelf Registration Statement 53 Exclusive License Agreement 52 Significantly Expands 52 Inovio Pharmaceuticals 52 Lubiprostone 52 Fourth Quarter Dividend 52 Distribution Agreements 52 Thrombin 52 Biosimilar 52 Completes Financing 52 Tax Expense 52 FDA Orphan Drug 52 Revenue Grows 52 Patent Portfolio 52 Electroporation 52 Wholly Owned 52 Significantly Increases 52 Inflammatory Diseases 52 Related Costs 52 Revenues Decline 52 Report Analyzes 52 Option Grants 52 FDA Clearance 52 Argatroban 52 Secures Funding 52 Registered Trademark 52 Blood Thinner 52 Flagship Product